|
⚲
|
| Keyboard |
| Ingenito Gary
✚
|
|
|---|---|
| CIK # | 0001279473 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001279473] | |
| 4 | [0001279473] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Ingenito Gary |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-05-14 | Option exercise | 44,000 | $4.64 | 204,160 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-05-14 | Option exercise | 44,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-05-14 | Sell | 44,000 | $23.63 | 1,039,720 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-05-13 | Option exercise | 200,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-05-13 | Option exercise | 200,000 | $3.42 | 684,000 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-05-13 | Sell | 200,000 | $23.68 | 4,736,000 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-03-06 | Sell | 180,096 | $21.67 | 3,902,680 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-03-06 | Option exercise | 180,096 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-03-06 | Option exercise | 180,096 | $2.24 | 403,415 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-03-05 | Option exercise | 44,904 | $2.24 | 100,585 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-03-05 | Option exercise | 44,904 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-03-05 | Sell | 44,904 | $22.09 | 991,929 |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-02-14 | Tax withheld | 2,435 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 10,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 10,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-27 | Tax withheld | 3,541 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 9,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 9,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 7,349 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 7,349 | $0.00 | |
| showing 20 of 101 most recent transactions | |||||